BIO-FD&C CO.,LTD. Logo

BIO-FD&C CO.,LTD.

Develops active ingredients for cosmetics and pharma using a plant cell platform technology.

251120 | KO

Overview

Corporate Details

ISIN(s):
KR7251120002
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도미래로 30 A동 509호, 510호, 511호, 인천광역시

Description

BIO-FD&C CO.,LTD. is a biotechnology company specializing in research and development based on a proprietary, sustainable plant cell platform technology. The company develops and commercializes high-value active ingredients for the cosmetics, pharmaceutical, and food industries. Its product portfolio includes plant cell-derived materials, bioactive recombinant proteins, growth factors, and peptides, with a significant focus on anti-aging ingredients for cosmeceuticals. Leveraging advanced techniques such as bioreactor cultivation, radiofrequency-enhanced production of bioactive compounds (SMART-RC2), and plant cell cryopreservation, the company is also exploring the development of plant cell-based therapeutics, including antibodies and vaccines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-23 00:00
사업보고서 (2022.12)
Korean 1.2 MB
2023-03-08 00:00
기업설명회(IR)개최
Korean 6.7 KB
2023-03-08 00:00
주주총회소집결의
Korean 10.6 KB
2023-03-08 00:00
주주총회집중일개최사유신고
Korean 4.8 KB
2023-03-08 00:00
주주총회소집공고
Korean 96.8 KB
2023-03-08 00:00
의결권대리행사권유참고서류
Korean 88.2 KB
2023-02-16 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.6 KB
2023-01-31 00:00
주식등의대량보유상황보고서(약식)
Korean 57.7 KB
2023-01-20 00:00
신탁계약에의한취득상황보고서
Korean 35.5 KB
2022-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB
2022-11-24 00:00
타법인주식및출자증권취득결정(자율공시)
Korean 19.7 KB
2022-11-11 00:00
분기보고서 (2022.09)
Korean 1.0 MB
2022-10-19 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 26.2 KB
2022-08-16 00:00
반기보고서 (2022.06)
Korean 1.0 MB
2022-06-20 00:00
기타경영사항(자율공시)((국책과제선정(식물세포기반 플랫폼 기술을 활용한 성장인자와 항체의약품 개발 및 향 소재 제품의 글로벌 진출)))
Korean 9.1 KB

Automate Your Workflow. Get a real-time feed of all BIO-FD&C CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIO-FD&C CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIO-FD&C CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.